Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria (Plasmodium Falciparum)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01136850
What this trial is testing

Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea

Who this might be right for
Malaria in PregnancySexually Transmitted InfectionsAnaemia
University of Melbourne 2,793
Testing effectiveness (Phase 2)Study completedNCT01374126
What this trial is testing

Azithromycin Combination Therapy for the Treatment of Severe Malaria

Who this might be right for
Falciparum Malaria
Medical University of Vienna 75
Large-scale testing (Phase 3)Study completedNCT00214643
What this trial is testing

Efficacy of Fosmidomycin-Clindamycin for Treating Malaria in Gabonese Children

Who this might be right for
Malaria
Albert Schweitzer Hospital, Netherlands 160
Not applicableStudy completedNCT04289688
What this trial is testing

Health Itinerary of Young Children With Suspected Bloodstream Infection in Kisantu General Referral Hospital, DR Congo

Who this might be right for
Bloodstream InfectionHealth Care UtilizationMalaria,Falciparum+2 more
Institute of Tropical Medicine, Belgium 784
Testing effectiveness (Phase 2)Study completedNCT01614964
What this trial is testing

Studies of a Candidate Aminoquinoline Antimalarial (AQ-13)

Who this might be right for
Malaria
Tulane University 66
Post-approval studies (Phase 4)Study completedNCT00885287
What this trial is testing

Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania

Who this might be right for
Malaria, FalciparumHIV Infections
University of Copenhagen 830
Testing effectiveness (Phase 2)Ended earlyNCT02573857
What this trial is testing

Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection

Who this might be right for
Malaria
Medicines for Malaria Venture 16
Early research (Phase 1)Study completedNCT00414336
What this trial is testing

Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 150
Post-approval studies (Phase 4)UnknownNCT04829695
What this trial is testing

Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Cameroon

Who this might be right for
Falciparum Malaria
University of Yaounde 1 184
Not applicableStudy completedNCT02600767
What this trial is testing

Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil

Who this might be right for
Malaria
Centers for Disease Control and Prevention 79
Post-approval studies (Phase 4)Study completedNCT06928207
What this trial is testing

Private Medicine Retailer-based Trial of Malaria Tests and Conditional Treatment Subsidies Among Patients With Fever

Who this might be right for
Malaria Falciparum
Clinton Health Access Initiative Inc. 20
Not applicableStudy completedNCT00471666
What this trial is testing

Medical Implications of Coinfection With Malaria and Filariasis Parasites

Who this might be right for
MalariaFilariasis
National Institute of Allergy and Infectious Diseases (NIAID) 1,039
Post-approval studies (Phase 4)Study completedNCT00164359
What this trial is testing

Amodiaquine Plus Artesunate Versus Lapdap Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Malawi

Who this might be right for
Malaria, Falciparum
Centers for Disease Control and Prevention 212
Not applicableEnded earlyNCT00304980
What this trial is testing

Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV Status

Who this might be right for
Plasmodium Falciparum Malaria
Institute of Tropical Medicine, Belgium 3,000
Testing effectiveness (Phase 2)Study completedNCT05400655
What this trial is testing

Anti-malaria MAb in Kenyan Children

Who this might be right for
Plasmodium Falciparum InfectionMalaria
National Institute of Allergy and Infectious Diseases (NIAID) 912
Not applicableLooking for participantsNCT07009847
What this trial is testing

An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine

Who this might be right for
Malaria,FalciparumMorality
Serum Institute of India Pvt. Ltd. 2,308
Large-scale testing (Phase 3)Study completedNCT00484900
What this trial is testing

Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
Dafra Pharma 1,390
Early research (Phase 1)Study completedNCT01867463
What this trial is testing

Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 230
Large-scale testing (Phase 3)Study completedNCT01345240
What this trial is testing

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 705
Testing effectiveness (Phase 2)Study completedNCT05140278
What this trial is testing

Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate

Who this might be right for
Severe Malaria
University of Oxford 200
Next Page